|
Market Closed -
Nasdaq Stockholm
00:00:00 29/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 1,650.50 SEK | +0.61% |
|
+0.73% | -3.11% |
| 03:24pm | Stockholm bourse trades around flat at the open | FW |
| 09:18am | Hansoh Pharma to Challenge EU Marketing Revocation for Aumolertinib | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
AstraZeneca PLC(AZN)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
AstraZeneca PLC(AZN)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
AstraZeneca PLC(AZN)
EBIT
Dividend / Share (DPS)
Data source:
AstraZeneca PLC(AZN)
Cash or Net Debt
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
- Consensus AstraZeneca PLC
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
